# Hemispheric

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hemispheric

- Industry: Healthcare
- Headquarters: Tel Aviv, Israel
- Website: www.hemispheric.ai
- Total disclosed funding: $52M
- Latest round: Series A (Jul 15, 2026)
- Investors on record: 8

## About

Hemispheric, based in Tel Aviv, Israel, specializes in artificial intelligence solutions that interpret brain activity, aiming to enhance understanding in healthcare and neuroscience. Founded in 2019, Hemispheric focuses on creating AI-driven tools to analyze non-invasive brain activity. There are no references to company pivots or changes in operations.

Hemispheric's core product, the Descartes model, is a sophisticated platform designed to translate non-invasive brain activity into actionable insights. This model leverages the largest proprietary multimodal EEG and behavioral dataset, enabling it to decode a wide range of brain functions tied to perceptual, cognitive, emotional, and behavioral tasks. By providing quantitative, objective insights, Descartes aims to enhance decision-making processes, interventions, and outcomes tailored to individual needs rather than average responses. The product is designed for applications in various fields, including healthcare, neuroscience research, and mental wellness, and has potential use cases in improving treatment efficacy and personalizing healthcare protocols. Hemispheric serves a diverse client base that includes healthcare providers, research institutions, and technology developers across North America, Europe, and parts of Asia.Hemispheric generates revenue primarily through partnerships and direct sales of the Descartes model to businesses and research institutions. These transactions typically involve licensing agreements, where clients gain access to the platform and its capabilities for a specified duration, enabling them to integrate brain decoding insights into their operations. Revenue streams may also include subscription models for ongoing access to the platform, along with support services for protocol optimization and treatment efficacy measurement. The company focuses on providing tailored solutions, which may involve a one-time setup fee followed by recurring charges based on usage or feature access. Specific pricing plans are structured to accommodate varying client needs and the scale of deployment, emphasizing the platform's adaptability and comprehensive functionality across different sectors.

In July 2026, Hemispheric raised USD 52 million in Series A funding co-led by Hanaco Venture Capital, One Mind, Awareness Capital Management, Protocol Labs, Inc., L Catterton, OurCrowd, and ArtofIn Venture Capital Fund, with participation from Arkin Capital. The company will use the July 2026 funding to expand platform deployment, grow its brain data network, advance diagnostic approvals, and scale its U.S. team.

## Funding rounds

- Series A, Jul 15, 2026, $52M — L Catterton, OurCrowd, Arkin Capital, Hanaco Venture Capital, Protocol Labs, Inc., ArtofIn Venture Capital Fund, One Mind, Awareness Capital Management

## Investors

- L Catterton (https://capitalatlas.ai/funds/l-catterton) — Series A
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series A
- Arkin Capital (https://capitalatlas.ai/funds/arkin-capital) — Series A
- Hanaco Venture Capital (https://capitalatlas.ai/funds/hanaco-venture-capital) — Series A
- Protocol Labs, Inc. — Series A
- ArtofIn Venture Capital Fund (https://capitalatlas.ai/funds/artofin-venture-capital-fund) — Series A
- One Mind (https://capitalatlas.ai/funds/one-mind) — Series A
- Awareness Capital Management (https://capitalatlas.ai/funds/awareness-capital-management) — Series A